A New Day at FDA Leads The Way For Sarepta Therapeutics

Shareholders of Sarepta Therapeutics (Nsadaq: SRPT) could be excused for scratching their heads yesterday after the close when the common stock of the company traded down around 10% after what seemed to be positive news emanating from the FDA. In a highly anticipated press release, Sarepta announced the results of the company’s meeting with the FDA regarding the pathway to eventual approval for eteplirsen, a novel exon-skipping drug that shows tremendous promise in treating boys suffering from Duchenne’s Muscular Dystrophy (“DMD”).

Read more

Why the Bookies Are Wrong on Sarepta Therapeutics

The options market proves the old adage that there is no such thing as a free lunch. Investors who dabble in special situations expect that the marketplace knows the basic outlines of your thesis, and prices risk accordingly. That’s not to say you can’t make money betting on outcomes, just that the firms on the other side taking your wager always make sure that the table pays odds commiserate with the gamble.

Read more

Will Windows Phone Upend Conventional Wisdom?

(November 23, 2012) Last night’s Patriot rout of the sad-sack New York Jets had all the hallmarks of a turkey. As someone who shelled out green to see some green action I had seen enough red on the field for one night so I strolled on over to the Verizon Studio to check out the latest handsets on display. As expected, people were milling about playing with the dozens of new phones and tables on display, preferring the indoor digital toys to the schoolyard romp taking place outside.

Read more

Little Bear Investments LLC Supports CIT Bond Exchange; Seeks to Discuss with Company Amending Terms of Exchange for Certain Classes of Long Term Debt

October 02

NEW YORK–(BUSINESS WIRE)–Little Bear Investments LLC, (“Little Bear”) an owner of CIT Group, Inc. (“CIT”) (NYSE:CIT) debentures, approves of today’s release by the CIT Board of Directors and Steering Committee (collectively, the “Committee”) of the Offering Memorandum, Disclosure Statement and Solicitation of Acceptances of a Prepackaged Plan of Reorganization (the “Bond Exchange”). The Bond Exchange is designed to reduce the direct and indirect unsecured debt in CIT by approximately $5.7 billion. In order to accomplish this, the Bond Exchange offers certain bondholders the right to exchange existing unsecured bonds (“Old Notes”) for new secured bonds (“New Notes”) plus additional consideration consisting of new shares of preferred stock (“New Preferred”).

Read more from Better Be Business Wired.

Brendan Technologies Secures $600,000 Bridge Financing

Tuesday July 17, 8:30 am ET

CARLSBAD, Calif.–(BUSINESS WIRE)–Brendan Technologies, Inc. (OTCBB: BDTE – News), an analytical software company developing advanced commercial software for immunoassay and bioassay testing technologies, has secured a bridge financing totaling $600,000, led by Little Bear Investments LLC as the lead investor and facilitated by Midtown Partners & Co. LLC.

Read more

Little Bear Investments LLC Participates in Caprius, Inc. $2.5 Million Private Placement

Thursday March 1

NEW YORK, March 1 — Little Bear Investments LLC (“Little Bear”) announced today that it has once more participated in a private placement to purchase common stock and warrants of Caprius, Inc. (OTCBB: “CAPS” ). This is Little Bear’s second investment in Caprius as it also participated in a round of financing for the Company in February of 2005.

Read more

Page 1 of 612345...Last »

” Concentration is my motto – first honesty, then industry, then concentration. ” Andrew Carnegie